NHS National Framework - Generics Housekeeping/Supply Chain Resilience Products
Supplier: AMAROX LIMITED; Accord-UK Ltd; Aspire Pharma Ltd; B. Braun Medical Limited; Bowmed Ibisqus Ltd; DR REDDY'S LABORATORIES (UK) LIMITED; Drugsrus Ltd; Ennogen Healthcare Ltd; Farmak Pharmaceuticals; Fresenius Kabi Limited; Grindeks Kalceks UK Ltd; JCSH Pharma Ltd; Kent Pharma Ltd; Luye Pharma Ltd; MERCURY PHARMACEUTICALS LIMITED; Macleods Pharma UK Limited; Martindale Pharma; Medreich PLC; Milpharm Ltd/aurobinbdo Primary; Morningside Pharmaeuticals; Mylan; NOVUMGEN LIMITED; Neon Healthcare; Panpharma UK Limited; Pfizer Ltd; ROSEMONT PHARMACEUTICALS LTD; SVP Pharma Ltd; Seacross Pharmaceuticals Ltd; Teva UK Limited; Wockhardt UK Limited; hameln pharma ltd
- End date in notice
- 31 May 2027
- Value shown in notice
- £11,656,086Whole award value; not assigned to one supplier
About this figure
- This award names more than one supplier but does not divide the published value between them. The figure is shown for context and is not assigned to one supplier.
View record references
- Source
- Contracts Finder
- Award or lot reference
ocds-b5fd17-895230db-86c4-4f1f-8915-3b5a187451a2 / ocds-b5fd17-895230db-86c4-4f1f-8915-3b5a187451a2-1